258 related articles for article (PubMed ID: 8077332)
1. Identification of gonadotroph adenomas in men with clinically nonfunctioning adenomas by the luteinizing hormone beta subunit response to thyrotropin-releasing hormone.
Daneshdoost L; Gennarelli TA; Bashey HM; Savino PJ; Sergott RC; Bosley TM; Snyder PJ
J Clin Endocrinol Metab; 1993 Nov; 77(5):1352-5. PubMed ID: 8077332
[TBL] [Abstract][Full Text] [Related]
2. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.
Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW
J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365
[TBL] [Abstract][Full Text] [Related]
3. Recognition of gonadotroph adenomas in women.
Daneshdoost L; Gennarelli TA; Bashey HM; Savino PJ; Sergott RC; Bosley TM; Snyder PJ
N Engl J Med; 1991 Feb; 324(9):589-94. PubMed ID: 1899470
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine.
Kwekkeboom DJ; de Jong FH; Lamberts SW
J Clin Endocrinol Metab; 1989 Jun; 68(6):1128-35. PubMed ID: 2542356
[TBL] [Abstract][Full Text] [Related]
5. Gonadotroph cell adenomas of the pituitary.
Snyder PJ
Endocr Rev; 1985; 6(4):552-63. PubMed ID: 2416559
[TBL] [Abstract][Full Text] [Related]
6. Abnormal response of luteinizing hormone beta subunit to thyrotrophin-releasing hormone in patients with non-functioning pituitary adenoma.
Gil-del-Alamo P; Pettersson KS; Saccomanno K; Spada A; Faglia G; Beck-Peccoz P
Clin Endocrinol (Oxf); 1994 Nov; 41(5):661-6. PubMed ID: 7828356
[TBL] [Abstract][Full Text] [Related]
7. Gonadotroph cell pituitary adenomas.
Snyder PJ
Endocrinol Metab Clin North Am; 1987 Sep; 16(3):755-64. PubMed ID: 3319601
[TBL] [Abstract][Full Text] [Related]
8. The effect of thyrotropin-releasing hormone on gonadotropin and free alpha-subunit secretion in patients with acromegaly and functionless pituitary tumors.
Popovic V; Damjanovic S
Thyroid; 1998 Oct; 8(10):935-9. PubMed ID: 9827662
[TBL] [Abstract][Full Text] [Related]
9. Comparison of hormonal secretory behavior of gonadotroph cell adenomas in vivo and in culture.
Snyder PJ; Bashey HM; Phillips JL; Gennarelli TA
J Clin Endocrinol Metab; 1985 Dec; 61(6):1061-5. PubMed ID: 2414310
[TBL] [Abstract][Full Text] [Related]
10. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
Plöckinger U; Reichel M; Fett U; Saeger W; Quabbe HJ
J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337
[TBL] [Abstract][Full Text] [Related]
11. Secretion of uncombined subunits of luteinizing hormone by gonadotroph cell adenomas.
Snyder PJ; Bashey HM; Kim SU; Chappel SC
J Clin Endocrinol Metab; 1984 Dec; 59(6):1169-75. PubMed ID: 6436288
[TBL] [Abstract][Full Text] [Related]
12. Human pituitary null cell adenomas and oncocytomas in vitro: effects of adenohypophysiotropic hormones and gonadal steroids on hormone secretion and tumor cell morphology.
Asa SL; Cheng Z; Ramyar L; Singer W; Kovacs K; Smyth HS; Muller P
J Clin Endocrinol Metab; 1992 May; 74(5):1128-34. PubMed ID: 1569159
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin regulation of glycoprotein hormone and free subunit secretion in clinically nonfunctioning and somatotroph adenomas in vitro.
Klibanski A; Alexander JM; Bikkal HA; Hsu DW; Swearingen B; Zervas NT
J Clin Endocrinol Metab; 1991 Dec; 73(6):1248-55. PubMed ID: 1720125
[TBL] [Abstract][Full Text] [Related]
14. Serum alpha-subunit elevation after TRH administration: a valuable test in presurgical diagnosis of gonadotropinoma?
Gruszka A; Kunert-Radek J; Pawlikowski M
Endokrynol Pol; 2005; 56(1):14-8. PubMed ID: 16335668
[TBL] [Abstract][Full Text] [Related]
15. Gonadotroph adenoma in a premenopausal woman secreting follicle-stimulating hormone and causing ovarian hyperstimulation.
Djerassi A; Coutifaris C; West VA; Asa SL; Kapoor SC; Pavlou SN; Snyder PJ
J Clin Endocrinol Metab; 1995 Feb; 80(2):591-4. PubMed ID: 7852525
[TBL] [Abstract][Full Text] [Related]
16. Combined beta FSH and beta LH response to TRH in patients with clinically non-functioning pituitary adenomas.
Somjen D; Tordjman K; Kohen F; Baz M; Razon N; Ouaknine G; Stern N
Clin Endocrinol (Oxf); 1997 May; 46(5):555-62. PubMed ID: 9231051
[TBL] [Abstract][Full Text] [Related]
17. Thyrotropin-releasing hormone provokes abnormal follicle-stimulating hormone (FSH) and luteinizing hormone responses in men who have pituitary adenomas and FSH hypersecretion.
Snyder PJ; Muzyka R; Johnson J; Utiger RD
J Clin Endocrinol Metab; 1980 Oct; 51(4):744-8. PubMed ID: 6774992
[TBL] [Abstract][Full Text] [Related]
18. Structure-function correlations of human pituitary gonadotroph adenomas in vitro.
Asa SL; Gerrie BM; Kovacs K; Horvath E; Singer W; Killinger DW; Smyth HS
Lab Invest; 1988 Apr; 58(4):403-10. PubMed ID: 2451766
[TBL] [Abstract][Full Text] [Related]
19. Gonadotroph adenoma with secondary hypersecretion of testosterone.
Chamoun R; Layfield L; Couldwell WT
World Neurosurg; 2013 Dec; 80(6):900.e7-11. PubMed ID: 23201183
[TBL] [Abstract][Full Text] [Related]
20. TRH is a tonic secretagogue in growth hormone secreting but not in nonfunctioning pituitary tumors.
Somjen D; Tordjman K; Greenman Y; Kohen F; Ouaknine GE; Stern N
J Endocrinol Invest; 1999 Feb; 22(2):104-8. PubMed ID: 10195376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]